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Antimicrobial resistance (AMR) is a major threat to global health and economies, the harmful effects of 
which are disproportionately experienced by those living in Low- and Middle-Income Countries (LMICs). 
Tackling this complex problem requires multidisciplinary and multisectoral responses. In the last few 
years, there has been a growing acknowledgement of the vital role of social science in understanding 
and intervening on antibiotic use, a key driver of AMR. Existing reviews summarise evidence of specific 
aspects of antibiotic use and specific intervention types. The growing concern that our off-the-shelf 
toolkit for addressing antibiotic use is insufficient in the face of rising use across humans, animals and 
plants, requires that we take a fresh look at the ways we are understanding this problem and possibilities 
for solutions. The ambition of this report is to provide a timely intervention into this global debate, 
by formulating a conceptual map of the insights from the growing body of social science research on 
addressing antibiotic use conducted in a diverse range of economic, social, and health system settings 
around the world.
A series of panel presentations and discussions was held in 2020 with leading social scientists working on 
antibiotic use in different settings. Analysis of the proceedings of these panels, together with a literature 
review which snowballed from the work of the 76 researchers profiled through the antimicrobialsinsociety.




The domains for action on antibiotic use presented in this report raise important questions for the AMR 
community. First, how can we move from standardised approaches to developing, refining, and monitoring 
impacts of interventions locally? Second, what time horizons should we set for interventions that aim to 
address AMR, and what other impacts should we expect of efforts to optimise antibiotic use? Third, what 
forms of evidence are most relevant, and what professional and infrastructural investment is required 
for this to support meaningful and responsive evaluation? The analysis in this report suggests new forms 
of transnational and intranational engagements to address this pressing bio-social-political issue could 
provide a platform for widening the options for addressing antibiotic use and its associated challenges.
The Practices grouping, in which the majority of the social research on antibiotic use has 
been carried out over the years, focuses on addressing end user antibiotic use. It shows how 
scholarship has moved away from knowledge deficit models to embracing an ‘ecological’ 
approach and to considering practice as embedded in lives and livelihoods. This body of work 
emphasizes the centrality of the local context to identify possible targets for intervening to 
change practice. 
The Structures grouping assembles the growing body of work that understands antibiotic 
use as a product of economic and political conditions. This research draws from political 
economical perspectives to identify the ways antibiotics have taken on critical roles in modern 
societies. Based on research investigating water, hygiene, sanitation (WASH), health systems 
and the political economy, the report considers how interventions that target these societal 
structures might reduce recourse to antibiotics as a ‘quick fix’. 
The Networks grouping collates recent work that draws attention to the mundane networks 
of logics, classifications and flows within which antibiotics are entangled. Research exploring 
agricultural and development imperatives, global health architectures, and circulating 
discourses has revealed the material and meaningful connections between human and 
non-human actors – animals, medicines, microbes, technologies, for example – that extend 
through time and space far beyond the moment of antibiotic use. These studies help render 
visible for action the apparatus such as clinical guidelines, delivery chains and models of care 
that have previously been overlooked when studying and addressing antibiotic use.
The report identifies three main areas of focus of  
social science recommendations to address antibiotic use:
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Antimicrobial resistance (AMR) is a global threat to public health that has been increasingly recognised 
as a biosocial phenomenon requiring input from the social sciences, alongside biological and clinical 
sciences (Smith, 2015, WHO, 2015). Research funders have been proactive in developing specialist 
funding streams and initiatives to bring more social scientists into this field (Lambert, 2015) and into 
conversation with scientists from other disciplines (Tarrant, 2017). In the UK, these efforts were catalysed 
by the Economic and Social Research Council-appointed AMR Champion Helen Lambert, to foster 
research agenda-setting activities and an understanding of how the theoretical and methodological 
approaches across the social sciences can be applied to further our understanding of AMR and antibiotic 
use (Chandler and Hutchison, 2016, University of Bristol, 2016, Wood, 2016). One programme of work 
emergent from this effort was the Antimicrobials In Society Hub, one of seven consortium grants 
funded by Theme 4 of the UK Research and Innovation (UKRI) cross-council initiative on tackling AMR,1 
‘Behaviour within and beyond the healthcare setting’ (see Box 1).
1 https://mrc.ukri.org/research/initiatives/antimicrobial-resistance/tackling-amr-a-cross-council-initiative/
“Drug-resistant diseases already cause at least 700,000 
deaths globally a year, including 230,000 deaths from 
multidrug-resistant tuberculosis, a figure that could 
increase to 10 million deaths globally per year by 
2050 under the most alarming scenario if no action is 
taken”.
“The mechanisms which lead to antimicrobial resistance are biological. However 
the conditions promoting, or militating against, these biological mechanisms are 
profoundly social. How our farmers, vets, and regulatory systems manage livestock 
production for human consumption; how regulatory and fiscal frameworks 
incentivise or deter antimicrobial development, production and use; how the public 
and healthcare professionals understand, value and use antimicrobials; the context 
in which animals and humans interact; the ways in which particular groups of 
humans are exposed to particular microbial infections; all these are shaped by 
social, cultural, political and economic forces.”
“Huge quantities of antimicrobials, in particular 
antibiotics, are wasted globally on patients and 
animals who do not need them, while others who 
need them do not have access. Fundamental change 
is required in the way that antibiotics are consumed 
and prescribed, to preserve the usefulness of existing 
products for longer and to reduce the urgency of 
discovering new ones”
Interagency Coordination Group on 
Antimicrobial Resistance 2019 (p.1)
Professor Dame Sally Macintyre, 2014 (p.1) 




The Antimicrobials in Society (AMIS) programme (2017-2021) 
sought to develop and promote fresh perspectives to social studies 
of AMR. In addition to running empirical research programmes in 
Uganda and Thailand, the programme set up the AMIS Hub as a 
connecting platform for social researchers working on AMR. The AMIS 
Hub ran a 2018 symposium at the Royal Academy in London with 
participants representing over 40 countries2. 
The monthly newsletter has highlighted activity in the field and 
the website3 connects and promotes the work of social scientists 
working on AMR across human and animal health and around the 
world. The website also provides a curated library of essential social 
research readings with accessible summaries aimed at introducing 
those designing and implementing AMR policy as well as funders and 
researchers from the life sciences to social science insights.
In the short time since the UKRI and other funders around the world began to invest in social research 
on AMR, there has been a significant increase in activity including research publications. Lu et al. (2020) 
traced how the number of social science publications in this area has grown rapidly (Figure 1), with 
the latter two years seeing an increase in the numbers of publications from researchers based in Asia 
and Africa. As a proportion of the total volume of AMR research, however, two bibliometric analyses 
have shown that social science publications still make up a small minority (Frid-Nielsen et al., 2019, 
Haenssgen et al., 2018b), illustrating the continued dominance of the biomedical sciences in this field.
Figure 1 Number of antimicrobials social science research publications in the last decade. 
Reproduced from Lu et al. (2020) under the terms of a Creative Commons Attribution 4.0 
International Licence)
2 An abstract book, proceedings and videos from the Social Science and AMR symposium can be found here: 
  https://antimicrobialsinsociety.org/commentary/symposium/   
3 www.antimicrobialsinsociety.org
Box 1. Antimicrobials in Society
INTRODUCTION
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We now face the welcome challenge to synthesise and provide orientation around the findings from 
social research on AMR (Vedadhir et al., 2020). The field has expanded in multiple directions, with 
innovative and informative studies that have focused on medicines, microbes, patients, animals, 
care providers, policies, and much more. To capture the depth of this research, synthesis will require 
segmenting the field, for example by disciplinary or topic dimensions. The reasons for antibiotic use in 
particular patient groups or particular health sectors warrant their own in-depth reviews. The effects 
of particular types of intervention on AMR, and antibiotic use, have already led to a large number of 
systematic reviews and better understanding effects will require further collaborative efforts (Wernli et 
al., 2020). 
In this report, we respond to the need for a birds-eye conceptual map that captures the breadth of 
insights from the growing body of social science research. Some of the impressive contributions of 
arts and humanities research to inform efforts to address AMR has recently been nicely summarised, 
highlighting how such scholarship can help to challenge circulating assumptions, offering novel ways to 
think, see, understand and present the phenomenon of AMR (Macduff, 2020). A policy brief for WHO-
Europe describes how understanding the cultural dimensions of antibiotic use and AMR transmission 
is critical in addressing AMR (Ledingham et al., 2019). In this report, we focus specifically on the topic of 
antibiotic use, and the types of insights for action that have emerged from social research. 
INTRODUCTION
In this report,  
we respond to the need 
for a birds-eye conceptual 
map that captures the 
breadth of insights from 
the growing body of 
social science research
A variety of fresh perspectives from social theory 
have been applied across multiple settings 
around the globe to the topic of antibiotic use. 
The increasing number of excellent research 
studies have explored and explained different 
aspects of antibiotic use, drawing on disciplines 
that include anthropology, sociology, geography, 
history, philosophy, economics, psychology and 
design. These studies present insights into the 
ways that societies – and constituent groupings 
and architectures – use antibiotic medicines. 
Each provides ideas for response, in policy, programme or pilot form. The momentum for action on 
AMR at a global and national level has generated strong interest in the drivers of antibiotic use, and in 
‘what to do’. The growing concern that our off-the-shelf toolkit for addressing antibiotic use is insufficient 
in the face of rising use across humans, animals and plants, is met in this report with a fresh look 
at the ways we are understanding this problem and possibilities for solutions. Intervention studies, 
and implementation research within policy and programme roll-out, are on the rise.  This is a critical 
moment to join together insights from across the many social research projects that have generated 
new evidence and ideas in recent years, to inform the development of pilots, policy and programmes on 
antibiotic use (Minssen et al., 2020).
The ambition of this report is to provide a timely intervention to the global debate on how to address 
antibiotic use, by formulating a conceptual map of the insights of social science research. The report is 
intended to be usable by a range of actors within and beyond the AMR research, policy and programmes 
communities.
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The development of this report was a collaborative process within the AMR Social Science community. 
In mid-2020 an advisory committee was established from amongst researchers listed on the AMIS 
website4 to work towards a report and launch event in February 2021. The group agreed on themes and 
proposed speakers for a series of four online panels designed to provide an overview of antibiotic use 
research and its implications for practice (Box 2). Presenters were invited on the basis of their research 
locations in low-, middle- and high-income countries, with both human and animal health foci.
Methods
Panel Four: 
Antibiotic science, technology and infrastructures
  •  Charlotte Brives, University of Bordeaux
  •  Komatra Chuengsatiansup, Princess Maha Chakri Siridhorn Anthropology Centre
  •  Catherine Will, University of Sussex
  •  Nik Brown, University of York
4  www.antimicrobialsinsociety.org 
Box 2. 2020 Panels on Antibiotic Use Social Research
Panel One: 
Antibiotics as Care: health facility based
  •  Alex Broom, University of Sydney
  •  Paula Saukko, Loughborough University
  •  Justin Dixon, London School of Hygiene and Tropical Medicine
  •  Esmita Charani, Imperial College London
Panel Two: 
Antibiotics beyond health facilities: care, pharmaceuticals and 
markets
  •  Papreen Nahar, University of Sussex
  •  Marco Haenssgen, University of Warwick
  •  Susan Nayiga, Infectious Diseases Research Collaboration, Kampala
  •  Mark Davis, Monash University
  •  Helen Lambert, University of Bristol
Panel Three: 
Antibiotics beyond humans: ecologies, production
  •  Stephen Hinchliffe, University of Exeter
  •  Claas Kirchhelle, University College Dublin
  •  Salla Sariola, University of Helsinki
  •  Rijul Kochhar, Massachusetts Institute of Technology
METHODS
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Each panel comprised four speakers and a panel discussion chaired by either Clare Chandler (London 
School of Hygiene and Tropical Medicine) or Helen Lambert (University of Bristol) to draw out 
implications for research, policy and practice from across presentations. 5 Written summaries of the 
panels were prepared for analysis. An online survey was also circulated through the AMIS newsletter and 
advertised at the panel sessions. This provided academics beyond the 16 presenters with an opportunity 
to share their research, especially unpublished work or projects in progress, and the practical 
implications of their work. To complement the panel discussions and survey, the publication lists of 
members of the AMIS online community were searched for relevant outputs.
Data sources were uploaded into NVIVO 12 (QSR International Pty Ltd, USA) and thematically coded. 
Emerging themes were refined following their presentation at a meeting with a small cohort of advisory 
committee members. A draft report was then written and circulated to the full advisory committee 
members for their contributions.
5  Recordings and short summaries of the panel series are available online (https://antimicrobialsinsociety.org/events/
antibiotics-in-societies-panel-series-2020/).
METHODS
The report’s targeted approach in data collection 
is not intended to replace more systematic efforts 
to identify, map and synthesise the social science 
literature on AMR (Lu et al., 2020, Vedadhir 
et al., 2020). Furthermore, it does not seek to 
supplant existing reviews of antibiotic practices 
such as Aslam et al. (2020), meta-ethnographies 
synthesising qualitative insights such as Germeni et 
al. (2018), or reviews evaluating interventions, for 
example, McParland et al. (2018), Tonkin-Crine et al. 
(2017) and Wilkinson et al. (2018). Rather, it seeks 
to offer a conceptual map through which we might 
approach different ways to understand and address 
antibiotic use based on insights from socially 
informed research.
The core writing team were English speakers 
based in the UK, which limited the data 
sources consulted. We note that much of the 
cited literature has a first author based in 
the Global North. This presents illustration 
of the uncomfortable situation of initiatives 
– including research – on antibiotic use 
originating in the Global North, discussing 
challenges occurring in the Global South 
(Haenssgen et al., 2020a, Kirchhelle et al., 
2020).
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The report is organised into three sections that serve to group the field into three areas of focus: 
Practices, Structures and Networks. 
Figure 2 illustrates these three overlapping fields that were chosen over the subject-based panel 
themes as they offered a greater means for harmonising insights across studies.6 Appendix one 
provides a summary of the studies referred to in the preparation of this report, describing their 
settings, insights regarding antibiotic use and recommendations for practice.
Results
Figure 2 The three overlapping areas of social 
science focus when studying antibiotic use
RESULTS
6  https://antimicrobialsinsociety.org/commentary/addressing-antibiotic-use-report-launch-roundtable-event/
A major achievement in AMR social 
research has been the production 
of a large body of work that 
characterises how antibiotics are 
used in practice by patients, farmers, 
drug sellers, clinicians and others. 
PRACTICES
Key themes in this body of work are that 
antibiotic use does not primarily result from a 
deficit in knowledge about AMR but rather is 
related to a web of social, economic, political 
and historical conditions. Therefore, modifying 
antibiotic use requires addressing these wider 
issues in order to support change in practice.
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Knowledge deficit models
While there are information challenges for many end users of medicines regarding which antibiotics 
to use, and the specific antimicrobial sensitivity profiles for local pathogens (Pearson et al., 2018), the 
knowledge gap often assumed to be most important to address is a lack of understanding of drug 
resistance, which is thought to undermine appropriate use of medicines. A theme in common across the 
social science literature on AMR has been the observation that knowledge of resistance is insufficient to 
change antibiotic use practices. 
Social researchers note a tension between the focus of policies on raising awareness of AMR and the 
realities of antibiotic use (Lambert et al., 2019, Rodrigues, 2020). Analysis of AMR policy – such as the 
WHO’s Global Action Plan (WHO, 2015) and the UK’s review on AMR (O’Neill, 2016) – however suggests 
a persisting premise that ‘inappropriate’ antibiotic use can be reduced through raising awareness of 
the dangers of AMR, thereby triggering more prudent prescription, sale and consumption of antibiotics. 
Table 1 illustrates how, across settings and contexts, researchers have shown that the reasons for using 
antibiotics are not primarily linked to a knowledge deficit about the consequences for AMR of their 
overuse. Rather, this body of works points to multiple factors that shape antibiotic use.
Social scientists have highlighted that increased awareness of AMR does not neatly translate into 
predictable changes in beliefs or antibiotic use (Charani et al., 2019, Haenssgen et al., 2019b, Lambert 
et al., 2019). Perhaps counterintuitively, research with medical and veterinary practitioners from 
six countries in the global south found awareness of AMR translated in more ready use of next-line 
antibiotics (Pearson and Chandler, 2019). A systematic review of interventions seeking to improve AMR 
awareness and behaviours in the general public found the quality of evidence to be poor, largely based 
in high-income countries, with more well-designed, experimental studies needed (Price et al., 2018). In 
terms of infection prevention, social scientists have also questioned the efficacy of hand washing and 
hygiene knowledge and awareness campaigns, the effects of which have been found to be mixed and 
sometimes transient (Denyer Willis and Chandler, 2019, Pinto et al., 2020).
Table 1: Reasons for using antibiotics, other than 
knowledge deficits extracted from social science 
studies listed in appendix one
The role of hierarchy, communication and 
prescribing etiquette between staff.
Professional reputation management and risk 
mitigation.
Delayed treatment seeking by patients 
concerned about the cost/ hospitalisation.
Lack of an effective primary care system 
resulting in patients being gravely unwell on 
admittance.
Communication barriers between patients and 
hospital staff.
Diagnostic uncertainty and the lack of 
accessible local AMR data.
Hospital settings (Australia, India, Sri Lanka, UK)
High workloads resulting in rushed/ less 
collaborative decision making
Within the private sector, the influence of 
business models and imperative to make a profit.
The role of the pharmaceutical sector and their 
representatives in shaping prescribing ‘norms’.
The role of insurance companies in setting 
‘appropriate’ care thresholds.
Overcrowding and limited ability to follow 
infection control procedures.
Outdated but ingrained prescribing practices.
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Community settings (Australia, Bangladesh, China, India, Laos, 
Mozambique, Myanmar, South Africa, Thailand, Vietnam)
Agricultural and aquaculture setting (Bangladesh, Guatemala, India, France, UK) 
General public Primary care
Pharmacy, drug stores
Inaccessibility of affordable formal 
primary care and the necessity of 
self-care.
The unaffordability of taking time off 
work to attend healthcare or to be 
unwell.
Necessity to be well enough to care 
for family and/or livestock.
The role of family and other 
community members in co-
producing treatment seeking 
behaviour and appropriate antibiotic 
use.
The social roles of antibiotics beyond 
their biomedical characteristics.
Protecting investment in livestock 
and livelihoods.
Inaccessibility of affordable formal 
veterinary care.
Business models and the need to 
keep customers satisfied.
Lack of time to fully discuss the 
patient’s health and causes of ill 
health.
Concern about the patient’s ability 
to return in case their condition 
deteriorates.
Limited affordable treatment 
options available.
Professional reputation and 
managing the risk of complaints.
Perceived patient pressure to 
prescribe.
Outdated but ingrained prescribing 
practices.
Diagnostic uncertainty and the lack 
of accessible local AMR data.
Business models and the need to 
keep customers.
Helping those who cannot afford to 
remain sick for long time or cannot 
afford other treatment.
Circulation of fake prescriptions.
The role of the pharmaceutical 
sector and their representatives in 
shaping prescribing ‘norms’.
Limited access to training/ 
appropriate use information.
Lack of regulatory oversight and/or 
monitoring.
Perceived client demand.
Professional reputation and 
managing the risk of complaints.
Role of the pharmaceutical sector 
and their representatives in 
shaping prescribing ‘norms’.
Disease outbreaks caused 
by weather events and living 
conditions
Haenssgen et al. (2018b) and (Charoenboon et al., 2019) evaluated an educational scheme based on 
locally-adapted WHO-derived antibiotic information in villages in PDR Laos and Thailand respectively. 
Rather than seeking to convince lay people that their behaviour was wrong, the scheme aimed at raising 
awareness and developing an understanding of local people’s conceptions and behaviour. Despite 
spending time and resources on tailoring the activities to local context, both studies found that there was 
a very limited effect on behaviour. Careful mixed-methods evaluation found that the intervention had a 
number of unintended consequences, possibly inadvertently increasing antibiotic use and marginalising 
less privileged groups through their lesser availability to participate in the scheme. 
These findings add to the growing body of doubts about the preoccupation with awareness raising when 
tackling AMR (Haenssgen et al., 2018b). Charoenboon et al. (2019) concluded that alternative behaviour 
change approaches are needed that address contextual constraints such as precarity and lack of social 
support rather than perceived knowledge deficits.
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Reaching a correct biomedical diagnosis is often positioned as a central step in achieving ‘appropriate’ 
antibiotic use (O’Neill, 2016). Through the lens of knowledge deficits, diagnostic tests are seen as providing 
a mechanism to correct misjudgement of patients, carers and/or prescribers. As a consequence, the 
role of clinical or veterinary expertise and acumen are downplayed. Social science informed studies 
have questioned this framing, showing that diagnosis entails the collation and interpretation of different 
strands of knowledge, signs and symbols (Buller et al., 2020, Helliwell et al., 2019). It also is an emotive, 
relational process involving different groups of healthcare (or veterinary) practitioners and patients and 
their carers (Khine Zaw et al., 2018, Saukko et al., 2019, Saukko and Rousham, 2020) and their context 
(Haenssgen et al., 2019a). The frontline insights provided by these studies illustrate how, rather than 
replacing these forms of work, diagnostic test information adds another strand. Given this, introducing a 
diagnostic test to correct antibiotic use may have limited or unintended consequences. 
The AMR field might be understood to have inherited a preoccupation with the knowledge deficit model, 
which is common across public health and global health (Will, 2018). Social scientists have suggested that 
initiatives that seek to change people’s practices through increasing their awareness of risks can fall into 
the trap of assuming an ‘empty vessel’ – a perceived as ignorant so that a top-up of knowledge will set in 
motion behavioural change (Khan et al., 2019, Lambert et al., 2019). 
Ecological models
Social scientists have emphasized the breadth of behaviour change models, beyond simple dissemination 
of training or information, and the diversity of vantage points offered by the social science disciplines 
when seeking to address antibiotic use (Lambert, 2019, Lorencatto et al., 2018, Will, 2018). For example, 
Krockow et al. (2019) used the health beliefs model – which suggests that antibiotic use can be explained 
by people’s beliefs about ill health, perceived benefits and barriers to action and their self-efficacy – as an 
analytical framework when synthesising qualitative evidence on antibiotic use in hospitals. Based on this, 
Social scientists have 
suggested that initiatives 
that seek to change people’s 
practices through increasing 
their awareness of risks can 
fall into the trap of assuming 
an ‘empty vessel’ – a 
perceived as ignorant so that 
a top-up of knowledge will set 
in motion behavioural change
This not only ignores pre-existing 
understandings but assumes that populations 
who are the focus of such awareness-raising 
initiatives always have the ability to choose 
their behaviour and prioritise changing 
antibiotic use over other interests (Broom et 
al., 2017, Chandler, 2019, Haenssgen et al., 
2018a). The limitations of knowledge deficit 
models have long been acknowledged in 
the behaviour change (Dolan et al., 2010, 
Kollmuss and Agyeman, 2002) and health 
communication (Cho and Salmon, 2007) 
literatures, so why do they continue to 
form such a central part to our response 
to antibiotic use? Such models align with 
discourses that situate risk with citizens 
rather than requiring the state to intervene 
(Chandler, 2019). 
They also reflect the primary emphasis on individual actors in Western thought (Broom et al., 2020a), and 
the popularity of Knowledge Awareness Practice (KAP) surveys as tools to measure awareness from which 
our understanding of antibiotic use is largely derived (Haenssgen et al., 2020a). Public discourse analysis 
has identified how awareness campaigns entangle people in conflicting messages of taking responsibility 
for their health, whilst urging them to trust healthcare practitioners to act in their best interests; this is a 
possible explanation for the limited impact of such interventions (Lohm et al., 2020, Davis et al., 2020b).
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the need for interventions that manage the risk associated with decisions not to prescribe were identified, 
for example through organisational protection from personal litigation. 
Ecological models seek to frame behaviour in a wider context – recognising the close links between health 
and the socio-physical environment to help identify behavioural and institutional targets in order to 
change behaviour (Grzywacz and Fuqua, 2000). Much research on antibiotic use practices aligns with this 
perspective, focusing on the interaction between the social environment and decision making (Charani 
and Holmes, 2019, Haenssgen et al., 2019b). 
Antibiotic stewardship interventions – typically those in healthcare settings in the Global North – have 
been informed by behaviour change models including the Behaviour Change Wheel, which uses the 
COM-B (capability, opportunity, motivation and behaviour) model (Michie et al., 2011) to summarise 
the individual, socio-cultural, and environmental influences on behaviour (Lorencatto et al., 2018, PHE, 
2015, Thompson et al., 2020). Work in progress is using this model to develop policy recommendations 
based on insights from interviews with householders, drug shop staff and pharmaceutical company 
representatives in Bangladesh (Nahar, personal communication) and from a mixed methods study 
conducted in pharmacies, village clinics and township health centres in Anhui province, China (Zhao et 
al., 2019).
Wang et al. (2020) used the Socio-Ecological 
Model as a framework to investigate 
antibiotic dispensing without a prescription 
by pharmacies in China at intrapersonal, 
interpersonal, institutional and policy levels. 
Having identified the role of patient demand, 
the need to ensure economic survival, 
competition with other pharmacies, the 
use of fake prescriptions and the minimal 
consequences of providing antibiotics without 
prescription, they recommended standardised 
prescriptions, tracking of antibiotic sales data, 
and tighter regulations with higher fines for 
pharmacies contravening them – in addition to 
public education programmes.Photo credit: Roengit, Society and Health Institute,  
Ministry of Health, Thailand.
Ecological models seek to 
frame behaviour in a wider 
context – recognising 
the close links between 
health and the socio-
physical environment to 
help identify behavioural 
and institutional targets in 
order to change behaviour
In recent years, behavioural economics 
approaches – which seek to nudge individuals 
into behaviour change through targeting 
their automatic and reflective decision 
making – have gained popularity (Will, 2020b). 
Nudging the systems in which antibiotic use 
decisions are made has been proposed as a 
cost-effective means to alter antibiotic use as 
these approaches do not require investment 
in staffing or new technologies (PHE, 2015). 
Such nudges might include prescribing 
checklists so that clinicians do not relying on 
mental shortcuts that result in ‘inappropriate’ 
antibiotic use (Langford et al., 2020).
Even with this broader understanding of behaviour, questions remain about whether these frameworks 
sufficiently describe the dynamics of antibiotic use (Charani and Holmes, 2019, Will, 2018). Social research 
methods can provide a fuller picture by enabling the study of collectively produced understandings of 
illness, health and medicines use, for example (Lambert et al., 2019).
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Many researchers have illustrated the importance of understanding and responding to the everyday 
lives and livelihoods of those whose antibiotic use behaviour is of concern. Here, researchers question 
that antibiotic use is ‘irrational’, and rather propose that given the economic and cultural situations 
people are living and working in, current practices may better be understood as ‘rational.’ By attending 
to everyday realities in the cultural contexts of use (Ledingham et al., 2019), researchers try to identify 
potential leverage points for those seeking to modify antibiotic use, beyond communicating about 
‘appropriate’ antibiotic use (Will and Kamenshchikova, 2020).
Building on previous ethnographic work on antibiotics from around the world (for example Craig, 
2002, Nichter, 2001, Adome et al., 1996), a wealth of empirical cases is now available that describes 
how antibiotic use practices relate to lives and livelihoods in a range of settings. For example, within 
primary care in rural China (Chen et al., 2020, Lambert et al., 2019) and South Africa (Manderson, 2020); 
public and private hospitals in India (Broom and Doron, 2020, Broom et al., 2020b); community settings 
in Mozambique (Rodrigues, 2020), Bangladesh (Lucas et al., 2019, Nahar et al., 2020b) and Myanmar 
(Khine Zaw et al., 2021). Published studies have also explored antibiotic use in Bangladeshi aquaculture 
(Hinchliffe et al., 2018, Hinchliffe et al., 2020) and small holder poultry production (Masud et al., 2020); 
dairy farmers in India (Chauhan et al., 2018); and poultry farming in rural Guatemala (Snively-Martinez, 
2019).
Lives and livelihoods models
A range of methodologies and theories from social 
research have helped develop our understanding 
of people’s treatment seeking behaviour beyond 
a dichotomy of antibiotic use (yes/no) to include 
self-care, consulting a sequence of practitioners and 
drawing on multiple health systems. Haenssgen et 
al. (2018a) developed the activity space framework 
to support such conceptualisation of microlevel 
antibiotic use beyond individuals’ awareness 
and free choice. Rodrigues (2020) described the 
socioeconomic and therapeutic landscapes in which 
people make self-medication decisions in Maputo, 
Mozambique. In India, Chauhan et al. (2018) traced 
the biography of antibiotics as they moved through 
formal and informal routes into smallholder dairy 
farms. In Bangladesh, the PAUSE project explored 
the plural pathways by which households accessed 
antibiotics for themselves and their animals 
(Lucas et al., 2019). They found that a lack of 
regulatory infrastructure, perceived consumers 
demand, and medical pluralism played a part in 
‘inappropriate’ antibiotic use by both qualified 
and unqualified healthcare providers (Nahar et 
al., 2020b). This project draws upon the idea of 
medicines having ‘social lives’ (Whyte et al., 2002) 
to unfold how antibiotics eventually destined for 
human and animal consumption move through 
society taking on roles beyond their biomedical 
characteristics (Nahar et al., 2019). Recognising 
that medicines are social actors with their own 
materialities – physical characteristics extending 
beyond their antibiotic characteristics – is a 
currently underutilised avenue to support the 
identification of alternatives to antibiotics (Jamie 
and Sharples, 2020).
Studies of medicines use illustrate the 
vital importance of self-care practices and 
informal healthcare systems to provide 
access to antibiotics and to alleviating 
suffering in settings underserved by formal 
veterinary and medical services
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Photo credit: Roengit, Society and Health Institute, 
Ministry of Health, Thailand.
Based on observations and stakeholder interviews, 
Krockow and Tarrant (2019) compared how culture 
and the unique hospital environment in three 
countries – South Africa, Sri Lanka and the UK – 
combined to produce localised forms of prescribing 
dilemmas regarding antibiotic use. For example, in 
Sri Lanka a lack of accessible primary care, worries 
about missing work and loss of income resulted 
in patients being sicker on admission to hospital, 
limiting clinicians’ ability to enact conservative 
prescribing. In a linked paper, they concluded that 
antibiotic prescribing decisions involve dealing with 
doubt, and interventions could look at providing 
more support for prescribers in how to manage this 
uncertainty (Tarrant et al., 2020).
In their ethnographic study, Chen et al. (2020) 
described how antibiotic prescribing decisions 
in rural China encountered a complex and 
unpredictable environment including a lack 
of material resources, diagnostic uncertainty, 
changing healthcare policies and the necessity 
to engage in ‘safe practice’. The circulation of 
sub-standard or fake medicines also means 
that prescribers and patients cannot rely on 
them to have standard effect, causing them to 
deviate from prescribing protocols to maximise 
the chances for positive outcome (Broom et 
al., 2019). Based on research conducted in 
Bangladesh, Hinchliffe et al. (2020) developed 
the concept of ‘risk-practices’ to help identify 
opportunities to intervene by reducing risk of 
disease in food production and to avoid a one-
size-fits-all response to optimising antibiotic use 
based on norms derived from the Global North. 
Together these, and other, studies of medicines use illustrate the vital importance of self-care practices 
and informal healthcare systems to provide access to antibiotics and to alleviating suffering in settings 
underserved by formal veterinary and medical services. They indicate that engagement with plural health 
systems and informal providers by stewardship initiatives is necessary to ensure safe, accessible routes to 
antibiotics (Nahar et al., 2020a). This may necessitate novel responses beyond the regulatory approaches 
developed in the Global North, characterised by dominant formal, biomedical health and veterinary 
systems (Kirchhelle et al., 2020). These studies also indicate that to improve intervention effectiveness, 
social science methods and theories can be drawn upon in order to develop a nuanced and sympathetic 
understanding of healthcare seeking behaviour and medicine use.
Another reoccurring theme across studies is using antibiotic use as a means of attempting to manage 
uncertainty under precarious conditions. For example, precautionary prescribing practices may be 
encouraged by fears of cross-infection in clinics lacking sanitation, or concerns that patients will not – or 
cannot afford to – return follow-up appointments (Manderson, 2020, Pearson and Chandler, 2019).
Given the role antibiotics 
have in alleviating 
suffering, a starting point 
of equipping communities 
with the information 
they need to meet their 
healthcare requirements, 
rather than seeking 
to protect antibiotics 
from misuse, should be 
considered
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Through careful evaluation, they demonstrated that – by failing to understand local risk profiles derived 
from economic and ecological conditions – a stewardship intervention inadvertently caused increased 
reliance on antibiotic use (Hinchliffe et al., 2020).
Within and beyond these examples, market drivers and economic imperatives shaping forms of 
‘appropriate’ care and antibiotic use have been observed in a number of health and veterinary 
settings (Broom et al., 2018, Hinchliffe et al., 2018, Kirchhelle, 2018). In Bangladesh, Masud et al. (2020) 
documented the dependency of small-scale poultry producers on credit from poultry dealers who supply 
chicks, feed and antibiotics. Echoing the findings of Chen et al. (2020), they found social and economic 
capital to be an important determinant of antibiotic use (Masud et al., 2020).
Social scientists have also turned their attention to knowledge production practices surrounding 
‘appropriate’ antibiotic use and the positioning of biomedical understanding over local forms of knowledge 
within public health (Haenssgen et al., 2020a). In rural China, Lambert et al. (2019) described how local 
patterns of antibiotic prescribing resulted from specific knowledge-practice configurations that drew 
from both biomedicine and Chinese medicine, and were shaped by sociocultural, economic and systems 
drivers. By demonstrating the co-construction of medical knowledge between patients and health 
professionals within the social world, these findings highlight the need to move beyond unidirectional 
awareness campaigns that seek to impose orthodox, biomedical versions of ‘appropriate’ use onto local 
populations (Lambert et al., 2019). Given the role antibiotics have in alleviating suffering, a starting point 
of equipping communities with the information they need to meet their healthcare requirements, rather 
than seeking to protect antibiotics from misuse, should be considered. 
In addition to undertaking observational research, 
social scientists have also been concerned with how 
to better engage with local communities to support 
changes in antibiotic use. Cooke et al. (2020) piloted 
community-based participatory video making in 
Kathmandu to explore such issues. Mitchell et al. 
(2019) developed a ‘values and principles’ tool to 
support multiple stakeholders in developing locally 
tailored interventions that are clear, creative, 
evidence-led, interdisciplinary, equitable, sustainable 
and flexible. They note, however, that community 
engagement is underused within interventions 
to modify to antibiotic use and is hampered by 
language barriers – emphasizing the need to 
decentre antibiotic research efforts from the 
Global North (Veepanattu et al., 2020) – and 
limited methodological support (Mitchell et al., 
2019). Based on a mixed-methods case study 
set in Bangladesh, King et al. (2020) propose 
a transferable process based on dialogue 
for developing community engagement 
interventions. They suggest that working with 
existing community structures and health 
systems offers a means to produce culturally 
appropriate interventions in a sustainable and 
scalable manner (King et al., 2020).
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Section conclusion
The research summarised in this section helps to further our understanding of how an 
array of local contexts influences antibiotic use and generates hypotheses for addressing 
antibiotic use through pilots, policy and programmes. These studies illustrate the particular 
configurations of social, economic, political and historical factors in which antibiotic use is 
situated, moving beyond simplistic interpretations of knowledge driven practices. 
They have explored formal and informal pathways through which antibiotics and other 
medicines move through society, and their social functions. Social sciences approaches 
have helped to foster more holistic understandings that consider the biographies of 
medicines beyond the point of prescribing. These studies have also illustrated the 
interconnections between factors, demonstrating the need for comprehensive and 
transparent evaluation, including to  detect and measure unintended harms. For example, 
within private healthcare settings and animal production systems, measuring the impact on 
profit margins will help to assess the feasibility of the implementation of interventions. 
This group of studies is united in agreement that developing a local understanding is crucial 
when seeking to alter antibiotic use in a sustainable way while minimising unintended 
consequences. They have described contributing factors to antibiotic use far beyond 
knowledge deficits and psychological factors. Studies have assessed a range of mechanisms 
to change working environments, such as checklists and supervision models to help 
understand and manage risks. Further work is needed in local contexts to develop and 
evaluate relevant interventions. Key to this endeavour will be support for and value of such 
skillsets in professionals embedded in health systems.
The prevailing assumption of knowledge deficits and emphasis on supporting individuals to 
change their behaviour has meant that wider drivers of antibiotic use – such as inequitable 
burdens of ill health, fractured health systems, and entrenched poverty – have often 
been overlooked (Broom et al., 2020a, Denyer Willis and Chandler, 2019, Haenssgen et 
al., 2020b). In the next section, we describe studies investigating the structural conditions 
shaping antibiotic use, and reflect on the potential to of intervene via levels other than that 
of the individual.
These studies illustrate the particular 
configurations of social, economic, 
political and historical factors in which 
antibiotic use is situated, moving 
beyond simplistic interpretations of 
knowledge driven practices 
The previous section illustrated how 
the social sciences are contributing 
to a more nuanced, complicated 
and expanded understanding of the 
contexts in which antibiotic use occurs. 
Many of these studies have taken a 
classic ethnographic or qualitative 
approach grounded in the everyday 
lives of those who are typically voiceless 
in policy conversations. This has 
advantages of really ‘getting at’ lived 
realities, but it is not always well suited 
for teasing apart the intricacies of what 
happens beyond the view of those 
situated at the point of antibiotic use. 
STRUCTURES
In this section, we consider social 
science research that suggests our 
attention could move away from 
individuals, to consider the economic 
and political imperatives that shape 
modern societies and their reliance 
on antibiotics. Rather than seeking to 
‘fix’ individuals, what if we sought to 
address the societal structures they 
are caught up in?
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Political economy
Drawing on ethnographic research conducted in Tanzania and Uganda, Denyer Willis and Chandler (2019) 
explored the roles of antibiotics beyond their curative effects, demonstrating how they act as a ‘quick 
fix’ across settings and scales. Antibiotics were found to paper over the lasting effects of political and 
economic violence, manage the consequences of lacking sanitation systems, prop up fractured healthcare 
systems, and help to maintain productivity in humans and animals (Denyer Willis and Chandler, 2019).
Viewing antibiotic use as a quick fix for broken 
systems helps move our gaze to the structural 
drivers of antibiotic use and potential targets 
for longer term, systemic solutions. The World 
Bank has proposed that interventions acting 
indirectly on AMR – ‘AMR-sensitive actions’ – 
may have greater impact, improve equity and 
be more cost-effective in controlling AMR than 
direct interventions such as tighter controls 
on the sale of antibiotics without prescription 
(Jonas et al., 2017). A move towards antibiotic-
sensitive interventions has also been indicated 
by evidence from the studies below.
Viewing antibiotic use 
as a quick fix for broken 
systems helps move our 
gaze to the structural 
drivers of antibiotic use and 
potential targets for longer 
term, systemic solutions
In India, Doron and Broom (2019) described how ‘geographies of vulnerability’ are produced as 
people living in poverty are disproportionately exposed to pathogens through their livelihoods and 
living conditions. These conditions combine with the growing problem of AMR to increasingly divide 
communities, exacerbating poverty and marginalisation (Doron and Broom, 2019). Lifting their gaze 
from the moment of antibiotic use, they describe how environmental pollution caused by antimicrobial 
manufacturing by pharmaceutical companies, the policy setting landscape, and limited access to 
healthcare combine to create a ‘precarious disease landscape’ (Broom and Doron, 2020). These studies 
illustrate the inadequacy of educating antibiotic users about AMR under these conditions, and echoes an 
interdisciplinary systematic review that found addressing social determinants of poverty remains a crucial, 
but neglected, step towards preventing AMR (Alividza et al., 2018).
Some country-level analyses, which have 
compared AMR, antibiotic consumption and 
other quantitative indicators, have indicated 
that increasing access to clean water, improving 
sanitation, increasing public healthcare 
expenditure, and better regulation of the private 
health sector are necessary to reduce the global 
burden of AMR (Collignon et al., 2018, Hendriksen 
et al., 2019). These analyses emphasise the role 
of governance in prioritising such infrastructure 
and regulation, which they link to the incidence 
of infectious disease and the spread of resistant 
strains of bacteria and resistance genes.
Recently, a positive quantitative association 
between precarity – ‘a condition driven by 
contextual factors that deprive people of 
predictability and stability of their lives’ – and 
antibiotic ‘misuse’ has been observed using 
behavioural data from Thailand and PDR Lao 
(Haenssgen et al., 2020b). 
The authors call for interventions to engage with 
AMR-sensitive development policy in order to 
address the social conditions that shape how 
people experience and respond to ill health. 
Unless precarity is addressed, sustainable 
changes in antibiotic prescribing are unlikely to 
be achieved (Chaudhuri and Pradhan, 2021). 
The persistence of such structural challenges – alongside their often-invisible interlinkages – signifies, 
however, that systemic solutions cannot emanate under the conventional leadership of a ministry of 
health or the WHO. Local non-health actors including the for-profit sector, non-governmental, civil 
society, or faith-based organisations could potentially play a role in shedding light on the fractures in the 
system that are patched up with antibiotics and that the high-level policy gaze often overlooks.
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Water and sanitation
Access to clean water and sanitation infrastructure are critical to prevent infections and reduce the 
spread of AMR (WHO/FAO/OIE, 2020). Reducing the incidence of infection through effective sanitation, 
together with hygiene and infection prevention measures, is one of the five objectives of the WHO’s 
Global Action Plan on AMR (WHO, 2015). Recognising the structural roles antibiotic use plays in standing 
in for clean water and effective sanitation offers an additional argument for such structural interventions 
(Podolsky, 2018).
Landecker (2016, 2019) has described how the biological and the social worlds are continually shaping 
and reshaping one other with regards to antibiotic use and AMR. Using a similar biohistorical approach, 
Kirchhelle et al. (2019) traced how a fragmentated global response to typhoid control resulted in 
antibiotics being used to compensate for weak healthcare and water systems in low- and middle-income 
countries. These conditions fuelled the development of AMR and thus this international neglect is 
recorded in the genes of increasingly common forms of drug resistant typhoid.
The cost of infrastructural improvements is 
often considered prohibitively expensive. 
Instead infection prevention is reduced to 
behavioural changes such as handwashing, 
which has only short-term impacts (Naikoba 
and Hayward, 2001). The effectiveness of many 
community-focused interventions trialled in 
recent years has been disappointing (Cumming 
et al., 2019). In addition, evidence of effects 
on drug resistant infection of improved water 
and sanitation is surprisingly sparse. Pinto et 
al. (2020) systematically reviewed the impact 
of interventions designed to improve water, 
sanitation and hygiene (WASH) and biosecurity 
in agricultural communities on AMR, burdens 
of infection and antibiotic use. They identified a 
paucity of studies conducted in the Global South 
and those evaluating structural interventions. Photo credit: Magdalena Bondos, LSHTM.
Future social science informed research is 
therefore required to address knowledge gaps 
regarding sanitation and water infrastructures.
This research is particularly needed in cities 
with large informal settlements, which 
currently house over a billion people worldwide
Future social science informed research is therefore required to address knowledge gaps regarding 
sanitation and water infrastructures. This research is particularly needed in cities with large informal 
settlements, which currently house over a billion people worldwide. Models suggest that improvements 
in WASH infrastructure has the potential for large reductions in antibiotic use (Araya et al., 2016) and 
a significant reduction in AMR could be achieved with improvements in urban infrastructure and 
governance (Collignon 2018). The challenge for social science is to provide evidence of how to achieve this 




Gender is currently under-investigated when considering the geographies of vulnerabilities with regard 
to AMR (Saint, 2019). Thinking through how the phenomenon – and efforts to address antibiotic use 
– impact people in different ways can help to avoid inadvertently increasing inequity or designing 
ineffective interventions (WHO, 2018).
An interdisciplinary study underway in West Africa involving microbiologists, clinicians and social scientists 
is exploring the flow of AMR genes between humans, animals and the environment (Sariola et al., 2020), 
addressing a clear gap in the literature (Rousham et al., 2018). Interim ethnographic work has identified 
the overwhelming ‘stacking of lacks’: the additive and compounding effects of fractured health and 
veterinary systems, sanitation and laboratory infrastructures, making it difficult to know where to begin 
to intervene (Butcher et al., 2020). The results of this study, of pilots and modelling studies, would help 
inform policy makers of what to prioritise when making structural improvements.
Additional research is 
needed to understand 
how women might 
inadvertently be expected 
to fill the gaps in care, 
hygiene, and productivity 
if antibiotics no longer 
work or their use is 
restricted
Men and women encounter AMR differently: 
A wide body of evidence demonstrates 
that men’s need to perform to an idealised 
masculine norm means they often delay 
health seeking, choosing to self-medicate 
until they are physically unable to work, 
for example when unwell with tuberculosis 
(Chikovore et al., 2020). Women are more 
vulnerable to infections caused by resistant 
bacteria through their physiology – illustrated 
through the increased burden of urinary 
tract infections (Will, 2020a) - and via their 
reproductive role – particularly during 
childbirth with its associated risk of exposure 
to resistant bacteria (WHO, 2018).
In some occupational settings, the burden of caring for antibiotics – i.e. stewardship – is falling 
disproportionately on women (Tompson, 2021). Elsewhere, women are responsible for the majority of 
care-work as they look after children, relatives, animals (Lohm et al., 2020). 
Women, therefore, have been recognised as a key audience of public AMR awareness campaigns 
(PHE, 2019). Such targeting fails to consider the complex ways in which intrahousehold decisions are 
made: gendered roles and relations mean that women may have reduced decision-making power 
around when or where to seek care, and may not be able access to the economic resources needed. 
Interventions that essentialise women’s position in the household and fail to acknowledge the 
complex ways gendered power relations shape decision are likely to have unintended consequences 
(MacPherson & Tolhurst., 2021). Furthermore, additional research is needed to understand how 
women might inadvertently be expected to fill the gaps in care, hygiene, and productivity if antibiotics 
no longer work or their use is restricted.
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From a systems-perspective, health systems can be 
imagined as interconnected building blocks which 
influence antibiotic use (Tomson and Vlad, 2014). 
These components include access to medicines 
and technologies, for example laboratory and 
diagnostic equipment to support clinical decision 
making. If antibiotics are one of the few medicines 
available, then clinicians are compelled to use 
them when trying to care for their patents (Jones, 
2018). Health system financial arrangements shape 
the affordability and accessibility of antibiotics. 
Incentives that link medicine sales with healthcare 
provider incomes may foster conditions of ‘overuse’ 
(Broom et al., 2018). Addressing antibiotic use also 
Health systems
The lens of antibiotics as a quick fix for fractured health systems helps us to look beyond patients 
and healthcare professionals ‘overusing’ them. A scoping review of interventions to reduce antibiotic 
prescribing in low- and middle-income countries found that health system quality acted with 
bureaucratic processes, competition between healthcare providers, cultures of care and perceived 
patient demand to produce the prescribing context in which antibiotics are used (Wilkinson et al., 2018).
The lens of antibiotics as a quick fix 
for fractured health systems helps us 
to look beyond patients and healthcare 
professionals ‘overusing’ them
requires an understanding of the scale of the 
problem and information infrastructures are 
needed to collect and analyse data on antibiotic 
use, local epidemiology and resistance profiles 
(Kirchhelle et al., 2020). In terms of human 
resources, having sufficient trained staff who are 
competent in infection control, diagnosis and 
‘appropriate’ antibiotic use are needed. Finally, 
governance creates the regulatory conditions 
that foster the local patterns of antibiotic use 
and organisational attitudes towards antibiotic 
stewardship (Kirby et al., 2018). Strengthening 
these building blocks can help address antibiotic 
use (Tomson and Vlad, 2014).
Social science studies have illustrated how these building blocks act together to necessitate the use 
of antibiotics as a quick fix for weakened health systems. An ethnographic study in the emergency 
departments and wards of public hospitals in Bangladesh found that understaffing, overcrowding, and 
lacking hygiene and sanitation hampered adherence to ‘appropriate’ antibiotic use guidelines when caring 
for patients with diarrhoea (Biswas et al., 2020). In Sri Lanka, the use of broad-spectrum antibiotics by 
hospital clinicians provided them with a response to missing infrastructures and patient poverty that 
would take huge investment and extensive regulatory and policy intervention to address (Tarrant et al., 
2021). A mixed-methods study in Ghana identified how ‘inappropriate’ antibiotic use was driven by out-
of-pocket payments limiting contact with the formal health system and the affordability of complete 
antibiotic courses (Afari-Asiedu et al., 2020). They concluded that interventions are needed to enhance 
access to healthcare insurance, healthcare and affordable antibiotics.
The provision of universal health care coverage has been proposed as a key structural intervention in 
tackling AMR, in part by improving access to healthcare (Bloom et al., 2017, Jonas et al., 2017, Tayler et al., 
2019). Much of the discussion on how to achieve this Sustainable Development Goal has concentrated on 
reaching universal coverage rather than the form of care delivered (Prince, 2020). In the final section to 
the report, we will further reflect upon how global health architectures translocate certain models of care 
around the world and the implications this has on antibiotic use.
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Social security
The ways in which lives are dependent on antibiotics extend far beyond forms of ‘modern’ medicine, 
caught up in processes such as modernisation, medicalisation, urbanisation and globalisation (Broom et 
al., 2020a). Social scientists have also drawn attention to the contradictions between capitalism – with its 
inbuilt short-term imperatives of productivity and profit – and tackling AMR (Broom et al., 2020a, De Lima 
Hutchison et al., 2018). Based on ethnographic research conducted in an American pig farm, Blanchette 
(2019) traced the entanglements of human, animal and microbial bodies as they laboured under intensive, 
industrialised conditions and the health consequences this had not only for these workers but on the 
environment beyond.
Antibiotics have enabled livestock to be configured as predictable units of production, especially in highly 
time-sensitive, industrialised livestock farming (Kirchhelle, 2018). Bangladeshi shrimp producers described 
how they are forced to resort to ‘desperate measures’ of antibiotic use when confronted with increasingly 
common extreme weather events caused by climate change and disease outbreaks that would otherwise 
cause financial ruin (Hinchliffe et al., 2020). 
Similar observations were made in Thai orange 
orchards, where farmers reported antibiotics 
saving their trees and businesses from epidemics 
of citrus greening disease (Urapeepathanapong 
et al., 2021). Research in progress in Uganda is 
investigating the assemblages that underpin 
‘quick farming’: the rearing of exotic pig and 
poultry breeds which rely on antibiotics to 
maintain their health in novel conditions, and 
represent significant financial investments for 
their owners (Kayendeke et al., 2021).
A linked research project in Uganda is exploring 
the conditions that produce ‘chronic living’ in 
humans: in the absence of societal safety nets, 
workers living in informal urban settlements turn 
to antibiotics to manage recurring bouts of acute 
illness so to continue working (Nayiga et al., 
2020). In South Africa, healthcare practitioners 
in urban health clinics give antibiotics to their 
vulnerable patients partly to protect them from 
their unhealthy living conditions or in case they 
are unable to afford to return to the clinic if their 
illness worsens (Manderson, 2020). 
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How can we support people if we remove the 
safety net of antibiotic provision? Wider use of 
deferred (or delayed) prescriptions have been 
proposed whereby the patient/carer/farmer are 
given an antibiotic prescription but only use it 
if the condition does not improve (Spurling et 
al., 2017). However, this is based on pathways 
of care from the Global North and so might be 
ill suited in settings where regular health care is 
not affordable. Universal health care coverage, 
as discussed above, might be the ultimate 
societal safety net, perhaps funded by a national 
insurance type model. Smaller-scale insurance 
schemes could also be offered to farmers to 
compensate them if they were to lose animals 
to disease, reducing the need for preventative 
antibiotic use. Other pilots could evaluate the 
impact of schemes to enable paid sick leave to 
workers, to reduce the pressure on them to turn 
to antibiotics use for a quick fix for their health. 
Antibiotics have enabled 
livestock to be configured 
as predictable units of 






The crisis of AMR offers an inversion point that forces us to consider what a future without 
antibiotics might look like. In doing so, the roles of antibiotics as infrastructure in our 
everyday lives – that normally fade into the woodwork – are rendered visible (Chandler, 
2019). Recognising the infrastructural roles antibiotics have in propping up existing 
operational and social structures necessitates the re-evaluation of the political, economic 
and moral priorities shaping societies. It opens up accountability beyond blaming individual 
users of antibiotics to recognise the roles of political classes, health funders, employers, 
investors and insurers in fostering the conditions in which infrastructural antibiotics use is 
necessitated (Will, 2018, Broom et al., 2020a).
Antibiotics have become a lynchpin 
in our political-economic systems, 
simply removing them is not a realistic 
solution. Instead, interventions are 
needed that address the economic and 
political imperatives that require resort 
to antibiotics as quick fixes
Since antibiotics have become a lynchpin in our political-economic systems, simply 
removing them is not a realistic solution (Broom et al., 2020a). Instead, interventions 
are needed that address the economic and political imperatives that require resort to 
antibiotics as quick fixes (Chandler, 2019, Denyer Willis and Chandler, 2019). 
Inequity may be addressed through ensuring universal health care and strengthening social 
safety nets. In some settings this may mean strategies that focus on preventing hunger, in 
others, by enabling ill workers to excuse themselves from the social imperative of being 
productive by providing sick pay and allowing them time off work to recover without 
antibiotics.
A move towards AMR-sensitive interventions requires reconsideration of the timeframes, 
scale, vision and organisation of financing. It also necessitates extending an understanding 
of the antimicrobial ‘community’ beyond psychological and behavioural experts to include 
engineers, town planners and economists. Addressing antibiotic use through structural 
improvements such as improving working and living conditions, quality of care, hygiene 
and sanitation remains a distant goal (Manderson, 2020), and given this, it is perhaps 
unsurprising that the World Bank recommends a portfolio of AMR sensitive and specific 
interventions (Jonas et al., 2017).
Whilst reducing societal inequity will have benefits far beyond addressing antibiotic use, it 
is a complex challenge. In the next section, we reflect on whether there could be another 
scale at which to intervene, one that is less daunting than antimicrobial-sensitive structural 
interventions but, that is not expectant of individual-based responses.
This third section of our report 
highlights work that situates current 
patterns of antibiotic use as a 
product of not only of the practices 
and structures of people and 
society, but also from the material, 
organisational and connective fibres 
into which antibiotics are stitched. 
Rather than being a discrete level 
of analysis, these networks operate 
with, and are co-shaped by, practices 
and structures. 
This research brings to the fore 
the often serendipitous, residual 
and overlooked arrangements that 
antibiotic use has become a part of 
and that may be traceable as logics, 
classifications, commodity flows 
and information routes that connect 
different places, matter and scales. 
NETWORKS
Many researchers whose work we have 
grouped here draw on approaches from 
Science, Technology and Society (STS) studies. 
Such research is concerned with how and 
why knowledge production and technological 
innovation relates to and informs social and 
political milieus in particular times and places. 
Attention in such analysis is paid not only to 
people and groups as social actors, but also 
to physical and connective actors that form 
material and semiotic associations (Law, 
2019). 
These actors may be thought of as ‘networks’ 
that may not have been deliberately designed 
or created, but which – when rendered 
visible – enable an understanding of how 
phenomena have emerged and persist. In the 
following section, we outline some areas in 
which social scientists have begun to consider 
the networks that co-produce antibiotic use.
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Agriculture and development imperatives
A growing number of studies are considering the networks of people, farm animals, microbes, living 
conditions, markets, value chains, supply chains and regulations that make up ‘modern’ farming and 
aquaculture, through which antibiotic use patterns emerge (Begemann et al., 2020, Fortané, 2019, 
Hinchliffe et al., 2020, Urapeepathanapong et al., 2018). They are helping to address calls for the 
unpacking of how the underpinning logics and dynamics of animal production shape drug use (Bellet, 
2018).
Historical and sociological analyses have traced the development of industrialised forms of animal 
production that rely on antibiotic use. Kirchhelle (2018) tracked how, over the course of seventy years, 
a series of short-term, national regulatory reforms that were narrowly focused on antibiotic use did 
not challenge the growing structural conditions and ideals that necessitated antibiotic use across and 
through multinational supply chains on both sides of the Atlantic. As a consequence of policy focused 
on antibiotic use – rather than animal welfare or environmental harm – industrial and intensive livestock 
farming businesses were able to comply with regulations without having to fundamentally address their 
organisation or strategies of productivity and profitability (Fortané, 2020). Recognising the networks in 
which antibiotic use occurs can draw attention to other ways by which to improve animal health. For 
example, by tracing the development of intensive pig production in the UK, Woods (2019) decentres 
antibiotic use, placing it amidst changes in housing, husbandry and nutrition, other nodes through which 
to intervene.
Photo credit: Roengit, Society and Health Institute, 
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As a consequence of policy focused
on antibiotic use – rather than animal welfare 
or environmental harm – industrial and 
intensive livestock farming businesses were 
able to comply with regulations without having 
to fundamentally address their organisation or 
strategies of productivity and profitability
Modified forms of intensified farming initiated 
in the Global North have been translocated 
around the world, linked to the project of 
development which seeks to reduce poverty and 
malnutrition through the provision of affordable 
protein (Kirchhelle, 2018). The co-enactment 
of ‘competing’ global health discourses 
around protein consumption and AMR is also 
being used as a lens through which to better 
understand antibiotic use in these settings 
(Denyer-Willis et al., 2021). These researchers 
draw clearer connections between the logics 
of development through livestock keeping, the 
logics of health improvement through protein, 
and the logics of antibiotic use reduction. 
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A number of social science projects are underway to develop interventions that follow these approaches. 
The UKRI-GCRF One Health Poultry Hub is undertaking ethnographic studies to characterise the roles 
and interactions of actors within poultry production and consumption networks, assessing how ‘value’ is 
created and how money circulates, in order to identify leverage points  for intervening (One Health Poultry 
Hub, 2021). The EU-funded ROADMAP study, with fieldwork sites in Vietnam and Mozambique (Fortané 
and Gautier, 2020), seeks to encourage transitions towards prudent antimicrobial use along the food 
supply chain (Byg et al., 2020). The Swedish-led project ‘On the road to reducing AMR for all’ will consider 
the interaction of materials, competences and meanings that produce antibiotic use patterns in different 
animal species and countries, including Brazil. It aims to identify elements that can support the reduced 
use at a country, veterinary clinic or a farm level (Olmos Antillón, 2020).
Interventions are needed to address powerful business interests operating across jurisdictions with the 
resources to influence stewardship intervention efforts towards their organisational agendas (Kirchhelle, 
2018). At the other end of the spectrum, there are numerous ‘invisible’ small-scale livestock producers 
whose precarious livelihoods are subject to the economic imperatives of global production chains, 
and whose voices and expertise are typically absent from efforts to address antibiotic use (Hinchliffe 
et al., 2018). The threat of AMR offers an opportunity to reconsider configurations of modern livestock 
production, economic profit distribution and meat consumption (De Lima Hutchison et al., 2018).
Global health architectures
Tracing the shifting priorities, models and programmes that make up the architecture of global health 
through time and space can render visible how ideas of ‘appropriate’ or ‘irrational’ medicine have been 
produced. The development of technical apparatus – research methodologies, clinical guidelines, delivery 
chains and medical curricula, clinical spaces among many other things – and the ways in which they are 
manifested create ‘grooves’ or channels through which commodities, ideas, knowledge and investments 
flow. They are integral to ways of representing and intervening – part of the taken-for-granted backdrop 
of global health. Tackling AMR, therefore, is bound up in the networks of power, command and control 
operating within Global Health (Hinchliffe, 2021).
Future work is needed 
to develop and pilot 
interventions that build 
in alternative forms 
of care amidst these 
underlying architectures 
of global health
One route through which antibiotics have 
been built-in to healthcare is in the design 
and layout of hospital buildings (Gradmann, 
2017). Architectural analysis has revealed how 
the introduction of these medicines replaced 
alternative means of managing the circulation of 
microbes such as ensuring fresh air and lower 
densities of hospital beds (Brown et al., 2020, 
Buse et al., 2020). AMR – and more recently 
COVID19 – has led to closer attention to the 
physical pathways taken by patients through 
healthcare facilities and to spatial models of 
care (Brown et al., 2019, Brown, 2020).
Historians are also tracing the evolution of networks of antibiotic use, innovation, AMR and stewardship 
(Brazelton, 2019, Gradmann, 2016, Hobaek and Lie, 2019, Santesmases, 2018). Their analyses can help 
to better understand how we reached the status quo regarding accessing antibiotics, efforts to protect 
them and developing new agents (Podolsky et al., 2015). Interdisciplinary work underway at the University 
of Oslo is tracing the trajectories of active pharmaceutical ingredients and generic antibiotics as they 
are produced and exported from Asia to markets in east Africa, along historical and contemporary 
trade routes (Fjeld, 2020). Likewise, a recent historical analysis has explored how an abridged form of 
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biomedicine travelled to Malawi, Uganda and Zimbabwe through colonial health systems (Palanco Lopez 
and Chandler, 2020). Under these conditions, antibiotics enabled structures of Western medicine to be 
amended, for example, through reduced staffing models and healthcare professional coverage per capita. 
The effects of these networks and the roles of antibiotics persist in the organisation of health care systems 
(ibid). In Myanmar, Khine Zaw et al. (2021) investigated the gap between antibiotic use imagined by global 
health policy - in the form of WHO’s global action plan - and its enactment amidst local modes of political 
governance, histories of health systems and rule of law. They propose that the overlooking of these factors 
by policy makers, in favour of ‘template’ responses, risks inadvertently widening existing health inequities 
Photo credit: Roengit, Society and Health Institute,  
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and social injustices (Khine Zaw et al., 2021).
In Zimbabwe, Dixon et al. (2020) traced how twentieth century formations surrounding rational drug use 
(RDU) – supporting access to, and appropriate use of, essential medicines to improve population health at 
an affordable cost – contributed to antibiotic use being ‘built-in’ to everyday scripts – or models – of care 
followed by social actors. The more recent arrival of antimicrobial stewardship – with its sole imperative to 
protect medicines from ‘irrational’ use – brings its own pared down model of ‘appropriate’ medicine use. 
The introduction of clinical algorithms and diagnostics – in part, to ration access to medicines – can have 
unintended consequences (Chandler et al., 2016) and declare some patients as undeserving not only of 
medicines but of care (Dixon and Chandler, 2019). AMR therefore requires reconsideration of the ways in 
which pharmaceuticalised forms of healthcare have been worked into under-resourced health systems 
(Chandler, 2019, Dixon and Chandler, 2019). Future work is needed to develop and pilot interventions that 
build in alternative forms of care amidst these underlying architectures of global health.
A further network shaping  responses to antibiotic use is the global flow of metrics and data as part of 
efforts to better characterise the distribution of antibiotic use and AMR. Metrics typically emanate from 
influential organisations based in the Global North, whilst data are extracted from settings in the Global 
South as part of international attempts to quantify the magnitude of this global threat (Kirchhelle et al., 
2020, Chawraingern et al., 2021). 
The latter is hampered by a lack of laboratories, 
equipment and reporting infrastructures, 
resulting in datasets skewed towards settings 
in the Global North (Chandler, 2019). In 
consequence, international policy and 
stewardship endeavours may have limited 
resonance or utility in low resource settings, 
where frontline clinicians are more interested 
in the susceptibility of bacteria to their limited 
stock of antibiotics (i.e. what will work) than 
resistance (what will not) (Kirchhelle et al., 2020, 
Dixon et al., 2020). The Drug Bag method – 
developed in Africa and South East Asia – has 
been proposed by social scientists as a method 
by which to gather data on antibiotic use 
beyond formal healthcare settings (Dixon et al., 
2019), an addition to the portfolio of existing 
instruments measuring the use of antibiotics 
across the human, animal and plant sectors 
(WHO, FAO, OIE, 2020).
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Discourses of appropriate use
One-way social scientists have helped to render visible the circulating social scripts – the prevailing 
language and understanding – surrounding AMR and ‘appropriate’ antibiotic use is through discourse 
analysis of written and visual media, and of policy documents. By reflecting on the language, metaphors 
and images used, attention is drawn to how the problem is framed, who is attributed with responsibility 
for dealing with it, and what form these responses should take (Collins et al., 2018, Walker, 2020). These 
analyses help to render visible avenues for action currently obscured by these framings (Wernli et al., 
2017).
A diversity of voices 
and ways are needed to 
represent the complexities 
of antibiotic use and 
AMR, and reflect human, 
animal and environmental 
marginalisation and 
injustice
Scholars have also considered how multiple strands of knowledge regarding antibiotic agents and their 
effects are produced. For example, one arm of the ‘Marginalisation and the Microbe’ project is considering 
how different ways of knowing in microbiology, epidemiology, health economics and public health interact 
to shape policies on antimicrobial resistant infections, and the consequences for marginalisation in health 
care (Will, 2020a). Another area of interest has been bacteriophage, living bacteria-eating viruses, which 
could possibly offer a replacement for some uses of antibiotics. Kochhar (2020) traced the history of phage 
to contextualise their contemporary secular and sacred understanding amongst doctors, scientists and 
historians in Allahabad. Brives and Pourraz (2020) considered why their development as an antibiotic 
alternative has not been prioritised. They concluded that antibiotics shape assumptions about what can 
be known in terms of norms, categories and models of scientific evidence production – for example, 
the randomised controlled trial (Podolsky, 2010) – and, as a consequence, discourage the investigation 
of phage. How antibiotics act as epistemological infrastructure requires further consideration when 
developing programmes, policy and pilots for addressing antibiotic use.
Analysis based in the Global North has 
identified how framings of war (Nerlich, 2009, 
Walker, 2020), apocalypse (Irwin, 2020, Nerlich, 
2009), capitalism (Brown and Nettleton, 
2018), and migration (Brown and Nettleton, 
2017b) are drawn upon to explain AMR. The 
governments of high-income countries have 
been mobilised into acting partly due to high 
level policy documents framing AMR as a threat 
to economic growth and security (Khan et al., 
2019, Wernli et al., 2017). However, this framing 
has overlooked questions of development and 
equity, perhaps explaining the lack of attention 
to structural interventions described in the 
previous sections. 
Within the popular media, tensions between apportioning the problem of antibiotic ‘misuse’ to prescribers 
or antibiotic users or the broader community - the ‘unspecified we’ - have been observed (Brown and 
Nettleton, 2017a, Collins et al., 2018). In terms of reducing AMR, the story has been painted as one 
of scientific discovery with technical fixes: innovative antibiotics come to the rescue, while collective 
responses are downplayed (Brown and Nettleton, 2017b, Davis et al., 2020a). This framing obscures the 
potential of the social sciences, the arts and bioethics to contribute towards solutions in part by better 
understanding practices around antibiotic use (Irwin, 2020, Walker, 2020, Will and Kamenshchikova, 2020).
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Analysis of UK newspaper articles and One Health policy documents concerned with AMR from a range 
of settings found protecting human health was the central concern, while animal and environmental 
health sectors were assigned responsibility for addressing this problem (Kamenshchikova et al., 2019, 
Morris et al., 2016). Approaches beyond the dominant values of the human health sector, which foster a 
broader discursive space, are proposed (Kamenshchikova et al., 2019).
As already argued, the political economic structural conditions contributing to antibiotic use has 
been downplayed in popular discourses, with the responsibilities of the pharmaceutical industry and 
multinational industrial livestock producers largely overlooked (Collins et al., 2018, Walker, 2020). 
Scientific enquiry into environmental AMR is underpinned by implicit assumptions that current 
infrastructures and environmental pollution will continue to exist, and thus that ‘end-pipe’ management 
interventions are the solution to mitigate against the resulting health risks (Helliwell et al., 2020). 
The declining use of military metaphor in recent years coincides with the growing interest in the 
importance of symbiotic human–microbe relationships (Walker, 2020). The framing of the immune 
system as an army to keep out hostile invaders has been challenged as, more broadly, new ways of 
‘becoming’ with microbes are proposed (Brown, 2019, Brives, 2021, Davis et al., 2016, Greenhough et 
al., 2018, Lorimer, 2019). These changing conceptualisations of human-microbial relations impact our 
understanding of ‘appropriate’ antibiotic use (Grondal, 2018). As a consequence, new forms of symbiotic 
public health (Sariola and Gilbert, 2020) have been proposed that recognise the microbial impact on 
health beyond pathogenic disease (Lorimer, 2017). Further attention is needed to find ways to live with 
bacteria, including resistant forms (Giraud et al., 2019), as part of a postcolonial, ‘post colony’ global 
health (Hinchliffe, 2021).
A diversity of voices and ways are needed to represent the complexities of antibiotic use and AMR, and 
reflect human, animal and environmental marginalisation and injustice. (Helliwell et al., 2020, Walker, 
2020, Will and Kamenshchikova, 2020). Engaging sensitively with local practices and understandings of 
microbes, antibiotic use and AMR will foster the adoption of multiple framings, broadening our capacity 
to understand, communicate and act on antibiotic use and AMR (Will and Kamenshchikova, 2020).
Section conclusion
The studies described in this section have begun to make clear the mundane routes 
through which antibiotics have seeped into networks that form the backdrop to our lives. 
By highlighting these roles which otherwise would remain hidden, and by tracing these 
networks through time and space, fresh targets for antibiotic use interventions can be 
identified beyond the individuals at the interface of their use. 
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CONCLUSION
In this report we have collated insights from the growing body of high-quality social science research 
into antibiotic use in humans and animals in diverse settings. By bringing together research that 
investigates antibiotic use through practices, structures and networks, fresh perspectives for thinking 
and intervening emerge. These are summarised in Table 2.
The health and economic consequences of AMR are 
known to affect poorer countries disproportionately, 
and therefore addressing the problem in these 
settings is a priority (Jonas et al., 2017). This report 
has highlighted a small but growing number of 
studies conducted in Africa and Asia that draw on 
social theory to better understand antibiotic use. 
Table 2: How social science research can inform efforts to alter antibiotic use
Approach: PRACTICES STRUCTURES NETWORKS
Key message Antibiotic use practices are 
determined by wide social 
and material dimensions 
which must be addressed.
The structures that 
antibiotics are currently 
substituting in for must 
be invested in.
Existing public and global 
health architectures and 
conventions define antibiotic 
consumption and must be 





behaviour and practice 
by understanding and 
altering the context in which 
individuals make decisions 
about antibiotic use.
Interventions modify 
economic and political 
conditions to reduce the 
need for antibiotics to be 
used.
Interventions redesign 









prescribers and patients, 
providing information on 
medicines, awareness/
education tailored to local 
understandings of ill health 
and treatment.
Reduce inequity, 
prevent infection and 
support wellbeing by 
strengthening sanitation 
and health systems, 




& veterinary pathways/ 
protocols, strengthening 
supply chains and aid flows, 
adjusting accountability 
frameworks, recognising 
the project management 
orientation of global health, 
metaphors and words like 
stewardship and rational 
drug use.
The studies included this report clearly 
demonstrate the value in drawing upon the 
social sciences to produce a holistic and 
nuanced understanding of local antibiotic use. 
Their approaches are ripe for translocation to 





The research we have grouped as collectively concerned with practices reiterates the importance of 
understanding local contexts as a starting point to resist universal approaches and policy responses 
to address antibiotic use (Kirchhelle et al., 2020). An important next step is using these findings when 
designing and piloting interventions. To assist this, social scientists could collaboratively develop 
practical implications of their research, together with the key actors identified in their analyses. This 
would align with wider moves towards locally-tailored and holistic interventions that consider broader 
and unintended consequences on health and livelihoods, and incorporate sustainability dimensions 
(OECD Development Assistance Committee, 2019). 
These studies have demonstrated that, whilst knowledge and awareness play a part in antibiotic use, 
there are many other social, economic and political factors that intervention approaches are yet to 
consider. Pilot studies informed by more ecological models of behaviour that seek to adjust – or ‘tweak’ - 
the local environment would be valuable in informing efforts to intervene. They might potentially offer a 
more sustainable means by which to trigger longer-lasting changes to antibiotic use. The development of 
such an evidence-base would help to diversify options available to policy makers, especially in low- and 
middle-income countries hampered by a lack of information about what works (Dar et al., 2016). 
Social science studies are helping to develop a more sophisticated understanding of health care seeking 
behaviours and the role of self-care in settings in the Global South. In better understanding the plurality 
of antibiotic providers, stewardship efforts need to reach beyond their historical focus of hospitals and 
state-run primary care clinics. Engaging with informal providers requires piloting alternative approaches 
beyond regulation or the prohibition of over-the-counter sales that might drive ‘inappropriate’ antibiotic 
use underground. This includes challenging the starting point of such sales as ‘problematic’, and 
recognising their essential role in providing access to medicines for vulnerable groups.
Recognising social structures and the infrastructural roles of antibiotics necessitates that we, the AMR 
community, look beyond individuals and quick fixes. A change in perspective is required in terms of 
ambition and scale, for example, in relation to the impact and duration of improvements that we seek to 
make on people’s lives and living conditions. Addressing antibiotic use through repairing the political and 
economic imperatives is no small or speedy task. However, providing access to clean water, sanitation 
and hygiene is a matter of urgency, not only in terms of tackling AMR but as a broader priority for health 
and development (IACG, 2019). Given this, pilot studies measuring the impact of providing clean water 
on antibiotic use should not be necessary. Even so, social science informed evaluations  addressing less 
obvious structural interventions – such as creating avenues for sick pay – and how to support equitable 
access to high quality antibiotics in both human and animal populations will provide data with which to 
mobilise powerful political and policy players (Minssen et al., 2020).
A change in perspective is required in 
terms of ambition and scale, for example, 
in relation to the impact and duration of 
improvements that we seek to make on 




Considering the networks in which antibiotics are caught up in offers a novel approach through 
which to address antibiotic use. Understanding the connections between human and non-human 
components reveals the difficulties of intervening to ‘simply’ remove antibiotics from particular settings 
and situations. They may be so deeply built into pathways of care, for example, that they may be hidden 
and not be immediately obvious. Careful analysis of networks can help to identify counterfactuals to 
antibiotic use. Once obvious, interventions to address these networked uses of antibiotics might be 
easier to pilot than structural fixes. Tracing networks requires moving through time and space, and 
across country boundaries, beyond moments of consumption. Such approaches draw upon a range 
of research methodologies and emphasize the importance of interdisciplinary responses to address 
antibiotic use (Kamenshchikova et al., 2020, Macduff, 2020).
Discourse analyses on the social scripts we adopt to talk about AMR demonstrate a focus on technical 
answers to this ‘scientific’ problem. However, the research we describe has emphasized the need for 
a portfolio of collective, co-produced responses shaped by diverse perspectives and voices. We need 
to develop an architecture within global health that empowers countries to develop, implement and 
monitor their own approaches to address antibiotic use and support the professional development 
of those to undertake this work (Giles-Vernick et al., 2019, Haenssgen et al., 2020a, Veepanattu et al., 
2020). Such insights and reflexiveness should be included when educating public health students, health 
professionals and policymakers about addressing AMR.
We have referred to ‘the evidence’ regarding antibiotic use interventions. As part of a networks-type 
approach that questions categories and classification systems, it is worth reflecting on the types of 
evidence that we rely on to know how things ‘work’. The dominance of evidence-based medicine and 
of randomised controlled trials has resulted in an evidence-base oriented around what we can count 
(Lambert, 2006, Lambert, 2013). For example, quality of care becomes reduced to whether or not a 
treatment protocol was followed (Dixon and Chandler, 2019); complex health seeking pathways become 
whether or not an antibiotic was used (Haenssgen et al., 2020a). Fully capturing the downstream societal 
benefits from structural interventions or from avoiding AMR are difficult (Brives and Pourraz, 2020), and 
requires that we reconsider what counts in policy making and what implementation science involves.
Can we shift from a universalised and standardised approach to developing and 
defining interventions locally? What would this take for local professionals working in 
implementation science? What forms of knowledge sharing and professional development 
would this require, both locally and internationally? What benefits might there be for other 
areas of health in developing such approaches?
What time horizons should we set for interventions in AMR? The O’Neill report on AMR sets 
2050 as its time horizon, but our expectations from research and programmes are for very 
short-term impact interventions. Should we strategise for shorter, medium- and longer-
term investments to reduce our reliance on AMR?
What sorts of evidence should we make to understand changes that can impact antibiotic 
use? What would it take – methodologically, practically and financially – to generate such 
evidence in a reliable manner to feed back to investments in programmes? What lessons 
can be learned and synergies created with other programmes to evaluate policy impacts on 
health?
Reflecting on these three areas of focus gives rise the following 
questions of our ongoing research, programmes and policy:
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